Equities

Key statistics

As of last trade Novartis AG (NOVN:BRN) traded at 73.54, 0.00% above its 52-week low of 73.54, set on Jun 18, 2018.
52-week range
Today
73.54Jun 18 201885.46Jan 31 2018
Markit short selling activity
Low
Med
High
Open73.90
High73.90
Low73.54
Bid73.54
Offer73.78
Previous close73.54
Average volume375.00
Shares outstanding2.55bn
Free float2.46bn
P/E (TTM)21.72
Market cap187.82bn CHF
EPS (TTM)3.37
CHF
Annual div (ADY)2.80
CHF
Annual div yield (ADY)3.81%
Div ex-dateMar 06 2018
Div pay-dateMar 08 2018
Data delayed at least 15 minutes, as of Jun 18 2018.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.